The Stakeholder Engagement session was held on Thursday, 6 August 2026, at the Oyo State Primary Healthcare Board, State Secretariat, Agodi, Ibadan, focused on expanding access to Medogen SubQ, a World Health Organization prequalified (WHO PQ) Family Planning product produced
VIYA Health, the exclusive distributor of Incepta Pharmaceutical’s WHO PreQualified Family Planning solution, DMPA SC, in Nigeria, had strategic discussions with the Oyo State Primary Healthcare Board to expand access to quality, affordable family planning services across the State.
In his remarks, the Executive Secretary, Oyo State Primary Healthcare Board, Dr Muideen Babatunde Olatunji, welcomed the engagement and acknowledged the state’s long-standing openness to family planning initiatives and innovative programmes. In his remarks, he reiterated the State’s commitment to investing in health commodities, including strengthening the availability of family planning products, and collaborating in other areas of public health.
Dr Olatunji added that expanding access to a wider range of safe and affordable family planning options through the State’s Primary Health Centres will strengthen ongoing efforts to improve maternal and child health outcomes while empowering individuals and families to make informed reproductive health decisions.
“The Oyo State Government remains committed to improving access to quality primary healthcare services for our people. We commend VIYA Health for engaging with the Oyo State Primary Healthcare Board to expand access to safe, effective and affordable family planning commodities across our healthcare facilities. This collaboration will strengthen our healthcare delivery system and ultimately contribute to better health outcomes for women, children and families across the state,” he added.
Speaking during the meeting, the Business Lead, VIYA HealthNigeria, Billy Shoaga, a pharmacist said the ongoing collaboration reflects VIYA Health’s commitment to improving access to quality reproductive healthcare by working closely with State Governments and other key stakeholders.
Shoaga explained that increasing the availability of affordable, high-quality family planning commodities is critical to improving maternal and child health outcomes, reducing unmet family planning needs, and empowering women to make informed reproductive health decisions.
“At VIYA Health, we are committed to ensuring that quality healthcare products reach the people who need them most. Through our strategic collaboration with the Oyo State Primary Healthcare Board, we are expanding access to a WHO-prequalified family planning solution that combines quality, safety and affordability. We believe that stronger public-private collaboration will play a vital role in improving public health outcomes and ensuring that more women have access to reliable family planning options,” he said.
